申请人:ORION CORPORATION
公开号:US20160368906A1
公开(公告)日:2016-12-22
The present disclosure provides bicyclic heterocyclic derivatives of formula (I), which may be therapeutically useful, more particularly as bromodomain inhibitors; (I), in which R
1
, R
2
, R
3
, R
4
, L
1
, L
2
, Cy
1
, Cy
2
, X, n, and dotted line have the same meaning given in the specification, and pharmaceutically acceptable salts or pharmaceutically acceptable stereoisomers thereof that are useful in the treatment and prevention of diseases or disorders, in particular their use in diseases or disorders associated as bromodomain inhibitors. The present disclosure also provides preparation of compounds and pharmaceutical formulations comprising at least one of bicyclic heterocyclic derivatives of formula (I), together with a pharmaceutically acceptable carrier, diluent, or excipient.
本公开提供了公式(I)的双环杂环衍生物,可能在治疗上有用,更具体地作为溴结构域抑制剂;(I)中,R1、R2、R3、R4、L1、L2、Cy1、Cy2、X、n和虚线具有规范中给定的相同含义,以及其在治疗和预防疾病或疾病中有用,特别是在与溴结构域抑制剂相关的疾病或疾病中的使用。本公开还提供了制备化合物和包括至少一种公式(I)的双环杂环衍生物的药物配方,以及药学上可接受的载体、稀释剂或赋形剂。